Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia

Clinical trial NCT07199855 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT07199855

Sponsor

Zhejiang University

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2025-06-01

Primary completion

2027-06-01

Enrollment

24

View on ClinicalTrials.gov